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ABSTRACT  ;  
Simple and rapid spectrophotometric method was developed and applied to determine Glibenclamide (GB) by 
zero spectrophotometric method and first derivative spectrophotometric method for determining of (GB) in 
the presence of Metformin hydrochloride (MET). Zero spectrophotometric (ZS) method was applied for the 
determination of (GB) at λmax = 300 nm. Linearity range was (4 – 360) μg/mL. Regression analysis showed a 
good correlation coefficients R2 = 0.99993. The limit of detection (LOD) and limit of quantification (LOQ) were 
to be 0.65 μg/mL and 2.31 μg/mL, respectively.  First derivative spectrophotometric (1DS) method was applied 
for the determination of (GB) in the presence (MET). (GB) was determined at 317 nm (1D317). Linearity ranges 
were (4 – 240) μg/mL for (GB). Regression analysis showed a good correlation coefficients R2 = 0.999914. The 
limit of detection (LOD) and limit of quantification (LOQ) were to be 0.60 μg/mL and 1.83 μg/mL for (GB).  
The proposed zero spectrophotometry method was applied to analysis individual (GB), and the derivative 
(1D317) method was applied to analysis (GB) individually or combined with (MET) in Syrian trademark drugs. 
The proposed method is simple, direct, sensitive and do not require any extraction process. Thus, this method 
could be readily applicable for the quality control and routine analysis. 
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INTRODUCTION 
Chemically (GB) is 1-[4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulphonyl]-3-cyclohexylurea, is 
oral hypoglycemic drug sulphonyl  ureas  second generation act by inhibiting ATP-sensitive potassium 
channels in pancreatic beta cells. This inhibition causes cell membrane depolarization, which cause voltage 
dependent calcium channels to open, which causes an increase in intracellular calcium in the beta cell, which 
stimulates insulin release1-2. 
The estimation of (GB) from pharmaceutical formulations has been determining by several analytical methods. 
These include UV spectroscopy methods3-9, spectrofluorimetric method10, reversed-phase high-performance 
liquid chromatography         (RP-HPLC) methods11-12 and high performance liquid chromatography (HPLC)13-14, 
high performance thin layer chromatography (HPTLC)15-16. 
MATERIALS AND METHODS 
Apparatus 
All spectral measurements were carried out using a Spectro Scan 80 DV, UV/Vis spectrophotometer 
instrument Ltd (UK), connected to computer, quartz cells 1 cm. Ultrasonic bath Daihan (KORE), and stirrer 
VelpScientific, (Europe). Sartorius balance, sensitivity 0.01 mg. 
Chemical regents 
Glibenclamide (GB) : C23H28ClN3O5S, Mw = 494 g/mol from (China), its purity 99.9%;  potassium hydroxide: MW 
= 56.11 g/mol from (India), its purity 85 %. 
Stock standard preparation 
• Stock solution 4.05 × 10-3 M of (GB), MW = 494 g/mol, was prepared by dissolving 40 mg of (GB) in 
Potassium hydroxide  0.1 M, equivalent to 40.04 mg by taken the purity in consideration in volumetric 
flask  20 mL.The working standard solutions for zero spectrophotometric method were prepared by 
appropriate dilutions of stock solution 4.05 × 10-3 M in KOH 0.1 M to give concentrations between (4 - 
360) µg/mL of (GB).The working standard solutions for derivative spectrophotometric method were 
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prepared by appropriate dilutions of stock solution 4.05 × 10-3 M in KOH 0.1 M to give concentrations 
between (4 - 240) µg/mL of (GB). 
• Stock solution 0.1 M of potassium hydroxide, (MW = 56.11 g/mol) was prepared by dissolving 5.611 g of 
KOH equivalent to 6.60 g by taken the purity in consideration in volumetric flask 1000 mL. 
Calibration Curve 
To construct the calibration curve, five standard solutions for each concentration were prepared and the 
absorbance was measured of each solution five times. 
Sample preparation 
Two products were studied :  
• Twenty tablets from Glu-sta Syrian products were weighed and finely powdered and an accurate weight 
equivalent to 5 mg (GB) was accurately weighed, dissolved in volumetric flask 10 mL in KOH 0.1 M, then 3 
mL of the solution was taken to volumetric flask 10 mL and diluted to volume with KOH 0.1 M. 0.7 mL of 
the last solution was taken to volumetric flask 10 mL then diluted to volume with KOH 0.1 M. The result 
solution is theoretically equivalent to     10.5 µg/mL for (GB). 
• Twenty tablets from GLIBOMET Syrian products were weighed and finely powdered and an accurate 
weight equivalent to 2.5 mg (GB) was accurately weighed, dissolved in 10 mL volumetric flask in KOH 0.1 
M, then 3 mL of the solution was taken to volumetric flask 10 mL and diluted to volume with KOH 0.1 M. 
1 mL of the last solution was taken to volumetric flask 10 mL then diluted to volume with KOH 0.1 M, 
equivalent theoretically to 7.5 µg/mL for (GB). 
RESULTS AND DISCUSSION 
Zero spectrophotometry: Absorption spectra of the standard raw material samples 40 µg/mL (GB) and  15 
µg/mL (MET) solutions were recorded within a wavelength range of (225 – 350) nm against the blank 0.1 M of 
KOH (all the addition constituents without (GB) and (MET((.  
On the other hand, derivative spectrophotometry showed more resolution, where the determination of (GB) 
and (MET) mixture was possible without pretreatment. The first derivative spectrum at zero-crossing point was 
used to determine (GB) in the presence of (MET) at 317 nm, Fig. 1 . 
 
 
Fig. 1: First derivative spectra of: a- (GB), b- (MET). 
 
STABILITY OF STOCK SOLUTION 
Time effect on the stability of standard stock solution of (GB( in KOH 0.1 M was studied in three different 
concentrations    1.6 × 10-4 M, 2.4 × 10-4 M and 3.2 × 10-4 M. We did not notice any significant changes during 
the absorption measurement within two months. 
METHOD’S VALIDATION 
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The validity and suitability of the proposed method was assessed by linearity (evaluated by regression 
equation), limit of detection (LOD), limit of quantification (LOQ), accuracy (reported as percent %), precision 
(reported as RSD %), robustness, and Sandellʹs sensitivity. 
Linearity 
We studied the linearity of (GB) standard concentrations at the optimal conditions where we made a series of 
10 mL of separated volumetric flasks, each one contains variable concentration of (GB) stock solution 4.05 × 
10-3 M, and completed to 10 mL with KOH 0.1 M. Finally, we measured the absorbance at 300 nm for each 
concentration. Fig. 2 presents the (GB) spectra. The range of linearity was obeyed to Beer’s law in 






   Fig. 2: Spectra of (GB ) : 
            C1: 4 μg/mL, C2: 40 μg/mL,  
            C3: 80 μg/mL, C4: 120 μg/mL, 
            C5: 160 μg/mL,C6: 200 μg/mL, 
            C7: 240 μg/mL,C8: 280 μg/mL, 
            C9: 320 μg/mL, C10: 360 μg/mL. 
  Fig. 3: Calibration curve for (GB) : 
         C1: 4 μg/mL, C2: 40 μg/mL,  
         C3: 80 μg/mL, C4: 120 μg/mL, 
         C5: 160 μg/mL,C6: 200 μg/mL, 
         C7: 240 μg/mL,C8: 280 μg/mL, 
         C9: 320 μg/mL, C10: 360 μg/mL. 
 
The concentration linearity of (GB) in presence (MET) was in the range (4 – 240) µg/mL at 317 nm by 1D317, see 
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Fig. 4:First derivative spectra of Glibenclamide: 
          C1: 4 μg/mL, C2: 40 μg/mL , 
          C3: 80 μg/mL, C4: 120 μg/mL, 
          C5: 160 μg/mL,C6: 200 μg/mL, 
          C7: 240 μg/mL 
           
Fig. 5: Calibration curve forGlibenclamide: 
           C1: 4 μg/mL, C2: 40 μg/mL , 
           C3: 80 μg/mL, C4: 120 μg/mL, 
           C5: 160 μg/mL,C6: 200 μg/mL, 
           C7: 240 μg/mL 
 
Limit of Detection (LOD) and Limit of Quantification (LOQ) 
In spite of the measurement LOD and LOQ of (GB), five concentrations were analyzed in five replicates. LOD 
and LOQ for Glibenclamide were calculated by using the following equations:  
 ;  
Where SD, is the standard deviation of y intercepts of regression lines and m is the slope of the calibration 
curve. The limit of detection (LOD) and limit of quantification (LOQ) were for the first method (Zero 
spectrophotometry) 0.65 µg/mL and       2.31 µg/mL respectively. and were for second method (Derivative 
spectrophotometry) 0.60 µg/mL and 1,83 µg/mL respectively. 
Accuracy 
To determine the precision and accuracy of the proposed method, five replicate determinations were carried 
out on five different concentrations of standards (GB). The precision and accuracy results are presented in 
Tabe 1. 


















4 4.04 0.03 0.74 101.00 
120 120.33 0.94 0.78 100.28 
200 200.29 0.73 0.36 100.15 
280 279.86 0.85 0.30 99.95 





4 4.00 0.15 3.75 100.00 
40 39.97 0.19 0.48 99.93 
80 80.04 0.24 0.30 100.05 
160 160.04 0.98 0.61 100.03 
240 239.90 0.52 0.22 99.96 
  , mean of five replicated determinations, Accuracy (%) = (observed concentration/theoretical concentration x 
100 :                           Precision (RSD %) = (standard deviation/mean concentration) x 100. 
Precision 
In order to demonstrate the precision of the proposed method, intra-day and inter-day variability studies were 
performed at three different concentrations (20, 40, and 80) µg/mL for of standards (GB) at the same day in 
two hour's time interval and also at three different days. Method efficiency was tested in terms of RSD % for 
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both intra-day and inter-day precisions .  The precision was ascertained by carrying out five replicates of 
standard of standards (GB) under study and the mean was calculated. The results are showed in Tables 2 & 3. 
The RSD% results were not more than 1.51% and 1.85% for of standards (GB) using (ZS) method and of 
standards (GB) using (1DS) method  respectively, where the method is considered very precise. 


















20 20.17 0.61 20.19 1.51 20.12 0.70 
40 40.37 0.75 40.78 0.83 40.51 0.57 
80 80.21 0.33 80.40 0.56 80.29 0.37 
DS1 Glibenclamide 
20 20.52 0.91 20.31 1.19 20.38 1.40 
40 40.11 0.60 40.25 0.97 40.04 0.38 
80 79.84 0.65 79.42 1.34 79.49 0.58 
                    *n = 5  


















20 20.17 0.61 20.32 1.35 20.43 1.09 
40 40.37 0.75 39.96 0.37 40.11 1.29 
80 80.21 0.33 80.83 0.99 80.59 1.01 
1DS Glibenclamide 
20 20.52 0.91 20.45 1.49 20.26 1.85 
40 40.11 0.60 40.25 1.29 40.52 1.38 
80 79.84 0.65 80.18 1.15 79.77 0.70 
               *n = 5 
Robustness                                                                                                                                                              
 The robustness of an analytical procedure is a measure of its capacity to maintain unaffected results by a very 
small variation of some parameters and provides an indication of its reliability during normal usage. The 
studied variables parameters were slit, scan speed and the wavelength which performed at three different 
concentrations (40, 60 and 80) µg/mL for (GB). The results in Table 4 showed no significant difference 
Table 4: Robustness test. 
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              *n=5. 
Sensitivity Sandell’s and molar absorptivity  
Sensitivity of the proposed method for (GB) was determined by calculating Sandell’s sensitivity (SS), it was to 
be 0.378 µg/cm2. The mean molar absorptivity ε was found equal to 2613.8 L/mol.cm. 
RECOVERY 
The recovery was studied by three addition standards (80 %, 100 %, and 120 %) for every product.                    
  Table 5 presents the recoveries results for the two Syrian products (Glu-staand GLIBOMET). 




















1.14 1.14 99.76 18.79 8.36 10.45 
Glibenclamide  
  5 mg/tab. 
sta-Glu ZS 2.53 2.52 99.52 20.85 10.45 10.45 
2.19 2.22 101.19 23.14 12.54 10.45 
100.24 
2.66 2.68 100.60 18.81 8.34 10.42 
Glibenclamide  
  5 mg/tab. 
sta-Glu DS1 1.77 1.77 100.19 20.86 10.42 10.42 
2.30 2.30 99.92 22.91 12.50 10.42 
100.41 
2.41 2.43 101.00 13.49 5.97 7.46 
Glibenclamide 
2.5 mg/tab. 
GLIBOMET ZS 2.48 2.46 99.33 14.87 7.46 7.46 
2.74 2.76 100.89 16.49 8.95 7.46 
99.93 
2.44 2.42 99.16 13.41 5.98 7.48 
Glibenclamide 
2.5 mg/tab. 
GLIBOMET DS1 2.55 2.56 100.40 14.99 7.48 7.48 
2.44 2.45 100.22 16.48 8.98 7.48 
                                                 Meansfive separated determinations. 
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APPLICATION 
Estimation of Glibenclamide in Glu-sta and GLIBOMET products 
The developed method was applied for quantitative determination and identification (GB) in two Syrian 
pharmaceutical products (Glu-sta and GLIBOMET), for three different batches for each preparation. The 
samples were prepared as described in the section of samples preparation and analyzed. Quantitative analysis 
was done by using calibration curve. The obtained results are summarized in table 6. In general, the 
concentrations of the detected (GB). 
USP legislation17 indicate that the tablets must contain not less than 90.00 % and not more than 110.00 % of 
labeled amount. So, the obtained results are conformed to USP legislation17. The relative standard deviations 
RSD % (n = 5) of the quantitative results were in the range of 1.00 – 2.22% for Glu-sta and 1.61 – 1.98% for 
GLIBOMET, Table 6. 
Table6: Results of Glibenclamide in (Glu-sta and GLIBOMET) tablets. 
Method 
Product Glu-sta 5 mg/tab. GLIBOMET 2.5 mg/tab. 




4.98 5.07 4.96 2.49 2.52 2.55 
Range mg/tab. 4.96 – 5.07 2.49 – 2.55 
SD mg/tab. 0.05 0.11 0.11 0.04 0.05 0.05 
RSD % 1.00 2.17 2.22 1.61 1.98 1.96 
Range RSD % 1.00 – 2.22 1.61 – 1.98 
Per % 99.6 101.4 99.2 99.6 100.8 102.0 




4.96 5.02 4.84 2.53 2.49 2.57 
Range mg/tab 4.84 – 5.02 2.49 – 2.57 
SD mg/ tab 0.18 0.15 0.19 0.03 0.06 0.06 
RSD % 3.63 2.99 3.93 1.19 2.41 2.33 
Range RSD % 2.99 – 3.93 1.19 – 2.41 
Per % 99.2 100.4 96.8 101.2 99.6 102.8 
Range Per % 96.8 – 100.4 99.6 – 102.8 
Mean for five replicates.                                              
CONCLUSION 
We developed a new method which is suitable for the identification and quantification of Glibenclamide in raw 
material and Syrian tablets formulation. A good percentage of recovery shows that the method can be 
successfully used in pharmaceutical quality control and routine analyses. The proposed method is simple, 
sensitive, rapid, specific, a little cost.  It could be applied for quality control of Glibenclamide in pharmaceutical 
factories. The levels of Glibenclamide compounds in the analyzed preparations were found to be within the 
permissible limits set by the USP legislation17. 
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